Bimekizumab Safety in Patients with Moderate to Severe Psoriasis: Analysis of Pooled Data from Phase 2 and 3 Clinical Trials. J of Skin [Internet]. 2021 Jan. 1 [cited 2025 Apr. 19];5(1):s21. Available from: https://skin.dermsquared.com/skin/article/view/1174